Group 1 - The core viewpoint of the news is that *ST Jintai (SZ 300225) is expecting a significant decline in net profit for the first half of 2025, with projections between 7 million to 10 million yuan, representing a year-on-year decrease of 23% to 46% [1] - The main reason for the profit decline is the termination of cooperation with strategic reserve suppliers, which has led to an increase of 7 million yuan in bad debt provisions for other receivables compared to the same period last year [1] - To enhance market competitiveness, the company is increasing its investment in product research and development, resulting in a year-on-year growth in R&D expenses [1] Group 2 - As of the report, the market capitalization of *ST Jintai is 2 billion yuan [2] - The revenue composition for *ST Jintai in 2024 is 68.8% from non-main engine manufacturers and 31.2% from main engine manufacturers [1]

[I. Current Period Performance Forecast](index=1&type=section&id=I.%E3%80%81Current%20Period%20Performance%20Forecast) This section details the forecast period and estimated net profit for H1 2025, both showing a significant year-over-year decline [1. Performance Forecast Period](index=1&type=section&id=1.%E3%80%81Performance%20Forecast%20Period) This chapter specifies the performance forecast period from January 1, 2025, to June 30, 2025 - The performance forecast period is from January 1, 2025, to June 30, 2025[3](index=3&type=chunk) [2. Estimated Performance](index=1&type=section&id=2.%E3%80%81Estimated%20Performance) This chapter details the estimated net profit and non-recurring net profit for H1 2025, both indicating a significant year-over-year decline - The estimated performance type is a **year-over-year decline**[3](index=3&type=chunk) Key Financial Indicators for H1 2025 Performance Forecast | Indicator | Estimated for Current Period (RMB 10,000) | Prior Year Same Period (RMB 10,000) | Year-over-Year Change Range | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of Listed Company | 700.00 – 1,000.00 | 1,299.45 | Decrease 23% – 46% | | Net Profit Attributable to Shareholders of Listed Company After Deducting Non-recurring Gains and Losses | 400.00 – 600.00 | 1,179.52 | Decrease 49% – 66% | [II. Communication with Accounting Firm](index=1&type=section&id=II.%E3%80%81Communication%20with%20Accounting%20Firm) This section clarifies that the financial data for this performance forecast remains unaudited by an accounting firm - The financial data related to this performance forecast has not been audited by an accounting firm[4](index=4&type=chunk) [III. Explanation of Performance Changes](index=1&type=section&id=III.%E3%80%81Explanation%20of%20Performance%20Changes) This section explains the performance decline, citing increased bad debt provisions and higher research and development expenses - Due to the termination of cooperation with a strategic reserve supplier, the provision for bad debts on other receivables increased by **RMB 7 million** compared to the prior year[5](index=5&type=chunk) - To enhance product market competitiveness, the company continuously increased product research and development efforts, leading to a year-over-year increase in R&D expenses[5](index=5&type=chunk) - The combination of these factors resulted in a decrease in the company's net profit compared to the prior year[5](index=5&type=chunk) [IV. Other Related Explanations](index=1&type=section&id=IV.%E3%80%81Other%20Related%20Explanations) This section addresses non-recurring gains and losses, preliminary data disclosures, and investment risk warnings [1. Impact of Non-recurring Gains and Losses](index=1&type=section&id=1.%E3%80%81Impact%20of%20Non-recurring%20Gains%20and%20Losses) This chapter discloses the estimated impact of non-recurring gains and losses on net profit attributable to shareholders for H1 2025 - The company estimates that non-recurring gains and losses will impact net profit attributable to shareholders by approximately **RMB 3.8 million** for the first half of 2025[6](index=6&type=chunk) [2. Data Disclosure and Risk Warning](index=1&type=section&id=2.%E3%80%81Data%20Disclosure%20and%20Risk%20Warning) This chapter emphasizes the preliminary nature of forecast data, subject to the final semi-annual report, and warns investors of investment risks - The data in this performance forecast is a preliminary estimate by the company's finance department, with specific financial figures to be detailed in the '2025 Semi-Annual Report'[7](index=7&type=chunk)[8](index=8&type=chunk) - Investors are advised to exercise caution in their decisions and be aware of investment risks[8](index=8&type=chunk) [V. Documents for Reference](index=2&type=section&id=V.%E3%80%81Documents%20for%20Reference) This section identifies the Board of Directors' explanation for the 2025 semi-annual performance forecast as the reference document - The document for reference is the Board of Directors' explanation regarding the 2025 semi-annual performance forecast[9](index=9&type=chunk)

证券代码：300225 证券简称：*ST金泰 公告编号：2025-083 上海金力泰化工股份有限公司 关于股东公开征集表决权的公告 股东海南大禾企业管理有限公司保证向本公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 本公司及监事会全体成员保证公告内容与信息披露义务人提供的信息一致。 海南大禾企业管理有限公司（以下简称"海南大禾"或"征集人"）作为上海金 力泰化工股份有限公司（以下简称"公司"）持股14.80%的股东，根据《证券法》 《公开征集上市公司股东权利管理暂行规定》等有关规定，向公司监事会提交《关于 股东海南大禾企业管理有限公司公开征集表决权的公告》，海南大禾作为征集人，就 公司拟于2025年9月12日召开的2025年第三次临时股东大会有关议案向公司全体股东征 集表决权。 一、征集人声明及承诺 1、征集人作为持有公司 1%以上有表决权的股东，符合《中华人民共和国证券法》 第九十条、《上市公司股东会规则》第三十二条、《公开征集上市公司股东权利管理 暂行规定》第三条规定的全部公开征集条件。 2、征集人按照法律、行政法规、中国证监会规章、规范性文件以及深圳证券交易 所的规定，依法开 ...

Core Viewpoint - The company *ST Jintai is facing significant scrutiny from regulators due to questionable financial transactions and internal disagreements among board members regarding the response to regulatory inquiries [3][4][5][6]. Group 1: Regulatory Inquiry - In early July, the Shanghai Securities Regulatory Bureau issued an inquiry letter to *ST Jintai, focusing on large financial transactions with related traders and equity investment matters [5]. - The company reported abnormal fund transfers with several trading companies, with over 900 million yuan in prepayments and refunds, while actual procurement was only about 29 million yuan, indicating a severe imbalance [5]. - An audit indicated a major risk of fund misappropriation, particularly concerning the company's dealings with equity investments and the flow of funds to unknown entities [5]. Group 2: Board Disagreements - On August 5, the board of directors held a meeting to discuss the response to the regulatory inquiry, but the proposal was ultimately rejected due to internal disagreements [8]. - Board member Liu Ruiming opposed the response, citing contradictions and insufficient investigation into the fund flow issues raised by the regulatory inquiry [8][9]. - Independent directors expressed concerns about the logic of the company's explanations regarding fund usage and the relationships with certain suppliers, questioning the validity of the claims made in the response [9]. Group 3: Legal and Compliance Issues - Reports indicate that a board member has filed a police report regarding potential fund misappropriation, escalating the situation and raising concerns among investors about the company's future [10][11]. - The company is under risk of delisting and faces increasing compliance and governance challenges if it fails to respond adequately to the regulatory inquiries [11].

上海金力泰化工股份有限公司 二、关于对第八届董事会独立董事候选人任职资格的审查意见 经审查，提名委员会认为：公司第八届董事会独立董事候选人徐丽慧女士、邦荔女 士、徐甲强先生不存在相关法律法规和《公司章程》中规定的不得担任董事的情形，不 存在被中国证监会确定为市场禁入者且尚未解除的情况，不存在重大失信等不良记录， 未受过中国证监会及其他有关部门的处罚和证券交易所纪律处分，具备担任上市公司独 立董事的履职能力。上述独立董事候选人已书面承诺参加最近一次独立董事培训并取得 独立董事资格证书。综上，提名委员会同意提名徐丽慧女士、邦荔女士、徐甲强先生为 1 公司第八届董事会独立董事候选人。 特此公告。 董事会提名委员会关于提名第八届董事会 董事候选人的审核意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司独立董事 管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管 指引第2号——创业板上市公司规范运作》及《公司章程》等有关规定，上海金力泰化工股 份有限公司（以下简称"公司"）第八届董事会提名委员会基于独立判断的立场，对公司 第八届董事会非独立董事候选人和独立董事候选人的任 ...

2025.08.14 本文字数：4099，阅读时长大约6分钟 作者 |第一财经周斌 大额采购资金经8家贸易商"季度循环"、股权投资的资金去向不明，*ST金泰（300225.SZ）近15亿资金异常流转的问询回复陷入争议。 *ST金泰在8月12日披露的监管问询回复中称，2024年，该公司为规避原材料价格上涨风险，采取"战略备库"措施，向贸易商支付超9亿元资金，实际采购 金额仅2900余万元，资金流向与采购需求严重背离。其中，供应商部分资金流向非经营实体，与芮奈贸易（上海）有限公司（下称"芮奈"）的资金往来涉 嫌存在非经营性资金占用情况。 不仅如此，*ST金泰去年还向深圳怡钛积科技股份有限公司（下称"怡钛积"）支付了两笔股权投资款，合计金额4.6亿元，资金最终流向的、真实目的不 明。但该公司一名董事长称，这些资金中的大部分，经层层划转，最终流向了配资公司。 对于这些回复内容，该公司3名董事并不认同，并投了反对票。董事刘锐明认为，此次回复"避重就轻，罔顾事实"，战略备库供应商是受同一主体控制的 资金通道，公司管理层与实际控制人裴剑等人勾结，以不干涉采购部之由行侵占公司资金之实。 另据8月13日公告，*ST金泰董事会审 ...

Core Viewpoint - *ST Jintai is facing scrutiny over nearly 1.5 billion yuan in abnormal fund flows, with significant discrepancies between the funds paid to suppliers and actual procurement needs, raising concerns about potential non-operational fund occupation and mismanagement [1][3][10] Group 1: Abnormal Fund Flows - In 2024, *ST Jintai reported nearly 1.5 billion yuan in abnormal fund flows, including over 900 million yuan for "strategic inventory" and 460 million yuan in equity investment payments [3][4] - The company disclosed that the actual procurement amount was only about 29 million yuan, indicating a severe mismatch between funds transferred and actual purchases [3][4] - The strategic inventory funds were transferred to suppliers, who then moved the funds to non-supplier entities, suggesting potential misuse of funds [3][6] Group 2: Strategic Inventory Practices - The company initiated a "strategic inventory" strategy to mitigate raw material price risks, but the audit committee found that this practice no longer aligned with normal procurement principles [2][7] - The actual procurement conversion rate from strategic inventory was less than 4%, with significant costs incurred from fund occupation [3][6] - The strategic inventory suppliers, particularly Rui Nai and Yue Rui, accounted for over 85% of the payments in 2024, indicating a concentrated risk in supplier relationships [6][8] Group 3: Equity Investment Transactions - The company engaged in two equity transactions involving Yitai Ji, with a total of 460 million yuan in payments, raising questions about the true purpose and flow of these funds [4][10] - The audit committee suggested that the funds for these transactions were linked to the strategic inventory, indicating potential non-operational fund occupation [10][11] - Concerns were raised about the flow of funds from related parties, with allegations of a closed-loop system that could lead to asset misappropriation [11][12] Group 4: Governance and Internal Disputes - Three board members opposed the company's responses to regulatory inquiries, citing concerns over management's handling of funds and potential collusion with actual controllers [1][8] - The audit committee highlighted discrepancies in the company's disclosures regarding supplier relationships and fund flows, suggesting a lack of transparency [7][8] - The company claimed no controlling shareholder exists, despite evidence suggesting that key suppliers are linked to the same controlling entity [8][12]

Core Viewpoint - *ST Jintai is facing scrutiny over nearly 1.5 billion yuan in abnormal fund flows, with significant discrepancies between procurement needs and actual expenditures, raising concerns about potential non-operational fund occupation and mismanagement [3][7][11]. Group 1: Abnormal Fund Flows - In 2024, *ST Jintai reported nearly 1.5 billion yuan in abnormal fund flows, including over 900 million yuan for "strategic inventory" and 460 million yuan in equity investments [7][8]. - The company engaged in a "seasonal transfer" of funds, with 9.31 billion yuan transferred out and the same amount returned, while actual procurement amounted to only about 29 million yuan, indicating a severe mismatch [7][10]. - The strategic inventory funds were primarily funneled through suppliers like Ruinai and Yue Rui, which received over 85% of the total payments in 2024 [10][11]. Group 2: Strategic Inventory Practices - The strategic inventory initiative, started in 2022, aimed to secure raw material supply and lock in prices, but the actual procurement ratio has drastically declined from 78.12% in 2022 to just 3.18% in 2024 [10][11]. - The cost of capital for these strategic inventory practices has increased significantly, with costs rising from 136.26 thousand yuan in 2022 to 756.05 thousand yuan in 2024 [10][11]. - The audit committee expressed concerns that the strategic inventory behavior in 2024 did not align with normal procurement practices and was likely aimed at manipulating financial reports [4][5][11]. Group 3: Equity Investment Anomalies - The company made two significant equity investments in Shenzhen Yitai Technology Co., totaling 460 million yuan, with unclear final destinations for these funds [3][8][16]. - The audit committee noted that the funds from these equity transactions appeared to be funneled back into the strategic inventory, suggesting a potential cycle of non-operational fund occupation [16][17]. - There are allegations that the funds from these transactions were used to mask the true financial state of the company, with claims of collusion among various parties involved [17][18].

大额采购资金经8家贸易商"季度循环"、股权投资的资金去向不明，*ST金泰（300225.SZ）近15亿资金 异常流转的问询回复陷入争议。 *ST金泰在8月12日披露的监管问询回复中称，2024年，该公司为规避原材料价格上涨风险，采取"战略 备库"措施，向贸易商支付超9亿元资金，实际采购金额仅2900余万元，资金流向与采购需求严重背离。 其中，供应商部分资金流向非经营实体，与芮奈贸易（上海）有限公司（下称"芮奈"）的资金往来涉嫌 存在非经营性资金占用情况。 不仅如此，*ST金泰去年还向深圳怡钛积科技股份有限公司（下称"怡钛积"）支付了两笔股权投资款， 合计金额4.6亿元，资金最终流向的、真实目的不明。但该公司一名董事长称，这些资金中的大部分， 经层层划转，最终流向了配资公司。 根据公告，该公司2024年战略备库预付款转化的实际采购（转化率）不足4%，实际占用资金成本为 756.05万元，实际采购节约成本184.73万元，扣除资金占用成本后，实际亏损571.32万元。 在2024年战略备库已经遭受损失的情况下，该公司今年仍然存在向芮奈等5家供应商转出及转回资金的 情况，合计预付款2.56亿元，退款1.21亿元，采 ...

本次权益分派股权登记日为：2025年8月19日，除权除息日为：2025年8月20日。 二、权益分派方案 本公司2024年年度权益分派方案为：以公司现有总股本剔除已回购股份0股后的 QFII、RQFII以及持有首发前限售股的个人和证券投资基金每10股派0.18元；持有首发 后限售股、股权激励限售股及无限售流通股的个人股息红利税实行差别化税率征收， 本公司暂不扣缴个人所得税，待个人转让股票时，根据其持股期限计算应纳税额 【注】；持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红 利税，对香港投资者持有基金份额部分按10%征收，对内地投资者持有基金份额部分 实行差别化税率征收）。 【注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股1个月 （含1个月）以内，每10股补缴税款0.04元；持股1个月以上至1年（含1年）的，每10 股补缴税款0.02元；持股超过1年的，不需补缴税款。】 三、股权登记日与除权除息日 证券代码：300225 证券简称：*ST金泰 公告编号：2025-082 上海金力泰化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导 ...